353233-19-9

Upstream product

• 496-62-8 D-xylal 
• 191276-09-2 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate 
• 353233-17-7 C₃₉H₃₄O₁₂ 

Downstream Products

• 353233-26-8 (S)-3-Cyclohexyl-2-{(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-hydroxymethyl-6-[(3R,4R)-3-((2S,3S,4R,5R,6S)-3,4,5-tris-benzyloxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-4-yloxy]-tetrahydro-pyran-4-yloxy}-propionic acid benzyl ester 
• 353233-23-5 (2R,3R,4S,5R,6R)-2-Hydroxymethyl-6-[(3R,4R)-3-((2S,3S,4R,5R,6S)-3,4,5-tris-benzyloxy-6-methyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-4-yloxy]-tetrahydro-pyran-3,4,5-triol 

Relevant academic research and scientific papers

Preorganization of the bioactive conformation of sialyl LewisX analogues correlates with their affinity to E-selectin

It pays to be organized: Steric repulsion between fucose and the methyl substituent of the adjacent tetrahydropyran reduces the distance between galactose and fucose in the E-selection antagonist 1 compared compounds that lack the methyl group. The effect